Quanterix names Masoud Toloue CEO, Hrusovsky Executive Chairman

Quanterix Corp

Masoud Toloue appointed CEO and elected to the Board effective April 25, 2022.
Toloue's base salary $550k; target bonus up to 100%; $2M equity grant (70% options/30% RSUs) vesting over 4 years.
E. Kevin Hrusovsky transitions from CEO to Executive Chairman through Dec 31, 2022; base $400k; $1.4M equity grant with continued vesting.
Succession was previously announced on March 1, 2022; this filing formalizes the changes.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Masoud Toloue

Class II director

QTRX · Quanterix Corp

Effective: 2022-04-25
Filed: April 29, 2022, 7:59 PM ET

Effective April 25, 2022, Dr. Toloue was also appointed to serve on the Company’s Board as a Class II director, with a term ending at the 2022 annual meeting of stockholders, and will continue to serve as the Company’s President.

Appointed

Masoud Toloue

Chief Executive Officer

QTRX · Quanterix Corp

Effective: 2022-04-25
Filed: April 29, 2022, 7:59 PM ET

Effective April 25, 2022, Masoud Toloue, Ph.D., President of Quanterix and Diagnostics, was appointed Chief Executive Officer of the Company.

Role change

E. Kevin Hrusovsky

Executive Chairman

QTRX · Quanterix Corp

Effective: 2022-04-25
Successor: Masoud Toloue
Filed: April 29, 2022, 7:59 PM ET

E. Kevin Hrusovsky has transitioned from his role as Chief Executive Officer and was appointed Executive Chairman of the Company’s Board of Directors (the “Board”), effective April 25, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Masoud Toloue was appointed as Class II director at Quanterix Corp.

Action: appointed
Role: Class II director

Exact text from the filing

Effective April 25, 2022, Dr. Toloue was also appointed to serve on the Company’s Board as a Class II director, with a term ending at the 2022 annual meeting of stockholders, and will continue to serve as the Company’s President.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Masoud Toloue was appointed as Chief Executive Officer at Quanterix Corp.

Action: appointed
Role: Chief Executive Officer

Exact text from the filing

Effective April 25, 2022, Masoud Toloue, Ph.D., President of Quanterix and Diagnostics, was appointed Chief Executive Officer of the Company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

E. Kevin Hrusovsky changed role as Executive Chairman at Quanterix Corp.

Action: transitioned
Role: Executive Chairman

Exact text from the filing

E. Kevin Hrusovsky has transitioned from his role as Chief Executive Officer and was appointed Executive Chairman of the Company’s Board of Directors (the “Board”), effective April 25, 2022.

View on SEC.gov

Quanterix Corp filing history →

Source: SEC EDGAR

accession 0001104659-22-053529

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.